CHICAGO — Can there be another Keytruda?
Merck CEO Rob Davis, whose company makes the $25 billion-a-year cancer medicine, says it …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
AL (immunoglobulin light chain) amyloidosis is a rare disease that often results in progressive organ dysfunction, organ failure and eventual death.
CAD is a rare blood disorder where B cells produce antibodies that destroy red blood cells. Credit: Siwakorn TH via Shutterstock. Recordati has reached an
It may be possible to detect ovarian cancer years in advance of actual symptom onset based on the molecular and genetic analysis of cells taken